Response to "Effect of tissue plasminogen activator dose and interval on stroke severity"

J Stroke Cerebrovasc Dis. 2014 Jan;23(1):198. doi: 10.1016/j.jstrokecerebrovasdis.2013.10.027. Epub 2013 Dec 2.

Authors

Demetrios J Sahlas¹, Linda Gould¹, Richard Swartz¹, Naufal Mohammed¹, Rhonda McNicoll-Whiteman¹, Fahd Naufal¹, Wieslaw Oczkowski¹

Affiliation

¹ Division of Neurology, McMaster University, Hamilton General Hospital, Hamilton, Ontario, Canada.

PMID: 24291015
DOI: 10.1016/j.jstrokecerebrovasdis.2013.10.027

No abstract available

Publication types

Letter
Comment

MeSH terms

Brain Ischemia / complications*
Female
Fibrinolytic Agents / administration & dosage*
Fibrinolytic Agents / adverse effects*
Humans
Male
Stroke / complications*
Tissue Plasminogen Activator / administration & dosage*
Tissue Plasminogen Activator / adverse effects*

Substances

Fibrinolytic Agents
Tissue Plasminogen Activator